EUVIMEDSkopri EUVIMED
Übersichtsarbeit

The Molecular Design of Type I Photosensitizers to Remodel Hypoxic Microenvironment for Advanced Cancer Theranostics

Huihui Lu, Jingjing Zhang, Jiayao Zhao, Yanan Li, Feifei An iD, Yichao Chai

ChemMedChem · 2026-11-26 · 21 (22)

DOI: 10.1002/cmdc.70576 ↗

At a glance

Übersichtsarbeit in ChemMedChem, published online on 2026-11-13. Written by Huihui Lu and 5 co-authors. Institution: The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Major MEDLINE topics: Photosensitizing Agents, Tumor Microenvironment, Neoplasms, Antineoplastic Agents. 138 references. Funded by: Natural Science Foundation of Shaanxi Province, Basic Research Program of Shanxi Province.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Photodynamic therapy (PDT) is significantly constrained in hypoxic tumor microenvironments (TMEs) because conventional Type II photosensitization depends strongly on molecular oxygen for efficient singlet oxygen generation. This limitation has stimulated increasing interest in Type I photosensitizers, which initiate photochemical reactions through electron or hydrogen transfer and can retain reactive oxygen species (ROS)‐generating activity under reduced oxygen availability. In some Type I PDT systems, additional oxygen‐regulating processes can further alleviate local hypoxia, thereby sustaining O 2 − ‐dependent downstream ROS generation while contributing to the modulation of the TME. These properties also support combination strategies with photothermal therapy, immunotherapy, or chemotherapy to enhance therapeutic outcomes. This review systematically examines Type I photosensitizers within a framework linking molecular design, photophysical and photochemical properties, mechanistic pathways, and biomedical applications. Their classification, structure–property relationships, and mechanisms of action are critically examined, with particular emphasis on recent advances in hypoxia‐tolerant PDT, multimodal combination therapy, and imaging‐guided theranostics. Finally, the remaining challenges and future directions are discussed with the aim of facilitating the translation of Type I photosensitizers from fundamental research toward clinical cancer theranostics.

Subjects

MeSH terms (MEDLINE)

Photosensitizing AgentsTumor MicroenvironmentNeoplasmsAntineoplastic AgentsDrug DesignTheranostic NanomedicineHumansPhotochemotherapyAnimalsReactive Oxygen SpeciesMolecular Structure

Author keywords

Type I photosensitizerantitumor mechanismscancer theranosticsphotodynamic therapyreactive oxygen species

Substances

Photosensitizing AgentsAntineoplastic AgentsReactive Oxygen Species

Authors and institutions

  • The Comprehensive Breast Care Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • College of Medical Imaging, Shanxi Medical University, Taiyuan, Shanxi, China.

ORCID profiles: Feifei An

Funding

  • Natural Science Foundation of Shaanxi Province
  • Basic Research Program of Shanxi Province

Cite

APA

Lu, H., Zhang, J., Zhao, J., Li, Y., An, F., & Chai, Y. (2026). The Molecular Design of Type I Photosensitizers to Remodel Hypoxic Microenvironment for Advanced Cancer Theranostics. ChemMedChem, 21(22). https://doi.org/10.1002/cmdc.70576

Vancouver

Lu H, Zhang J, Zhao J, Li Y, An F, Chai Y. The Molecular Design of Type I Photosensitizers to Remodel Hypoxic Microenvironment for Advanced Cancer Theranostics. ChemMedChem. 2026;21(22). doi:10.1002/cmdc.70576

BibTeX
@article{Lu2026,
  author = {Lu, Huihui and Zhang, Jingjing and Zhao, Jiayao and Li, Yanan and An, Feifei and Chai, Yichao},
  title = {The Molecular Design of Type I Photosensitizers to Remodel Hypoxic Microenvironment for Advanced Cancer Theranostics},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {22},
  doi = {10.1002/cmdc.70576}
}
Start for free →